Back to results
US 12,286,658 B2Granted
Enhancing formation of milk oligosaccharides (HMOs) by modifying lactose import in the cell
AssigneeDsm IP Assets B.V.
InventorManos Papadakis
Life of this patent
Estimating the term…
Abstract
This invention relates to a method of producing one or more human milk oligosaccharides (HMOs), in particular LNT and/or LNnT, in a genetically engineered cell comprising an enhanced oligosaccharide transport capability. The genetically modified cell comprises a series of genetic modification which enable the production of one or more HMO(s), and a series of genetic modification that enhances the transport of lactose and produced HMO(s).
Claims20
A genetically engineered cell capable of producing lactose-N-tetrasaccharide (LNT), lactose-N-neotetrasaccharide (LNnT), or LNT and LNnT and wherein the cell
- a) overexpresses one or more lactose permease genes,
- b) expresses a heterologous MFS transporter protein selected from the group consisting of:
- i. Vag with the amino acid sequence according to SEQ ID NO:
- 62, or a functional homologue thereof having an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO:
- 62,
- ii. Nec with the amino acid sequence according to SEQ ID NO:
- 66, or a functional homologue thereof having an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO 66:
- iii. Fred, with the amino acid sequence according to SEQ ID NO:
- 63, or a functional homologue thereof having an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO:
- 63,
- iv. Marc with the amino acid sequence according to SEQ ID NO:
- 64, or a functional homologue thereof having an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO:
- 64 and
- v. Bad with the amino acid sequence according to SEQ ID NO:
- 65, or a functional homologue thereof having an amino acid sequence which is at least 95% identical to the amino acid sequence of SEQ ID NO:
- 65, and
- c) expresses two or more glycosyltransferases selected from the group consisting of β-1,3-GlcNAc-transferases, β-1,3-Gal-transferases and β-1,4-gal-transferases, and
- d) expresses one or more polypeptides involved in the biosynthesis of activated sugars.
15 more elements
Dependencies are inferred from the claim text.